Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2007; 13(5): 748-753
Published online Feb 7, 2007. doi: 10.3748/wjg.v13.i5.748
Published online Feb 7, 2007. doi: 10.3748/wjg.v13.i5.748
Table 1 Demographic characteristics and medications of patients with CD and controls
| Characteristic | Patients | Controls |
| Age (yr) | ||
| Mean | 36.9 | 31.5 |
| Range | 18-73 | 25-45 |
| Sex | ||
| Female | 5 | 4 |
| Male | 5 | 4 |
| Duration of disease (yr) | 6.4 (± 3.9) | - |
| Concomitant medication | - | |
| None | 3 | |
| Mesalazine | 3 | - |
| Metronidazole | 2 | |
| Azathioprine | 2 | |
| Location of Crohn’s disease | - | |
| Small bowel | 4 | - |
| Small and large bowel | 6 | - |
| Fistulizing disease | 3 | - |
- Citation: Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Chios mastic treatment of patients with active Crohn’s disease. World J Gastroenterol 2007; 13(5): 748-753
- URL: https://www.wjgnet.com/1007-9327/full/v13/i5/748.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i5.748